complement C3

complement C3

Beta-1-C-globulin, factor A A 180 kD serum protein; normal concentration 70–150 mg/dL, which is ↑ in chronic inflammation, bile obstruction, amyloidosis, severe protein malnutrition; ↓ in complement activation, immune complex disease, immunologic disease, bacteremia, genetic disease
References in periodicals archive ?
(1-4) An elevated erythrocyte sedimentation rate (ESR), the presence of anti-dsDNA, and low complement C3 and C4 levels are factors associated with active nephritis.
They also measured expression of the estrogen-inducible proteins lactoferrin and complement C3.
Nylons are known to induce complement C3 activation and thermal treatments increasing crystallinity increase also complement C1 activation (3).
The inflammatory nature of this process has been observed in immunohistochemical examinations of specimens, which revealed the presence of a variety of immunocompetent cells, including macrophages, HLA-DR-positive cells, cells expressing beta-2 microglobulin, suppressor T cells, and complement C3. [10,11] Deposits of immunoglobulins (Ig) G, M, and A and complement C3 can be found along the resorption lacunae and in osteocytes and chondrocytes surrounding the affected areas (table).
Liszewski et al., "Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome," Blood, vol.
Complement C3 is an acute-phase reactant and a central component in activation of the complement system.
Mauger et al., "Identification and characterization of complement C3 receptors on human astrocytes," The Journal of Immunology, vol.
Use the method of direct immunofluorescence to detect accumulation of IgA, IgG, IgM, complement C3, C1q, and fibrinogen-related antigen (FRA) in renal tissues, and determine the fluorescence intensity under a fluorescence microscope: "-" indicated no or weak fluorescence; "+" indicated only clearly visible fluorescence; "++" indicated bright fluorescence; "+++" indicated dazzling fluorescent.
C-reactive protein (CRP), complement C3 (C3), triglycerides (Trg) and HDL-cholesterol were tested to predict risk for incident diabetes or coronary heart disease (CHD).
In this study, the improvements in disease-related parameters resulting from IMO-3100 treatment were associated with suppression of interleukin 6 (IL-6) and complement C3 and with induction of interleukin 10 (IL-10).
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.
Further, morphologic and biochemical parameters of estrogenicity, including uterine epithelial cell height and number, gland number, and induction of estrogen-responsive proteins lactoferrin and complement C3, mirror wet weight increases.

Full browser ?